Table 1. Summary of included studies.
Author | Study period | Region | Study design | Age range (years) | No of iGBS cases | Incidence (cases per 100.000) | Method for incidence estimation | CFR (%) |
---|---|---|---|---|---|---|---|---|
Alhhazmi | 2003–2013 | North America | Population-based surveillance | ≥ 15 | 1372 | 3.23 | Average of incidence by age group provided by article | - |
Barnham | 1978–1988 | Europe | Population-based surveillance | 25–86 | 6 | 0.24 | Estimated from cases per catchment population provided by article | 33.0 |
Bjornsdottir | 1975–2014 | Europe | Population-based surveillance | 19–90 | 139 | 2.19 | Average of incidence by age group provided by article | - |
Blumberg | 1992–1993 | North America | Population-based surveillance | 39.1–75.3 | 112 | 5.9 | Provided by article | - |
Bolaños | 1992–1999 | Europe | Population-based surveillance | 21–100 | 32 | 1.5 | Provided by article | 31.0 |
Bunyasontigul | 1999–2009 | Asia | Retrospective cohort study | 15.3–91.6 | 101 | - | - | 7.9 |
Camuset | 2011 | Africa | Prospective hospital-based study | 25–93 | 22 | 10.1 | Provided by article | 4.5 |
Collin | 2015–2016 | Europe | Population-based surveillance | ≥ 15 | 2225 (episodes) | 2.9 | Provided by article | 12.5 |
Cooper | 1991–1996 | North America | Retrospective hospital-based study | “adults” | 55 | - | - | 16.4 |
Crespo-Ortiz | 2004–2012 | South America | Retrospective & cross-sectional study | 17–83 | 57 | 0.90 | Estimated from cases per catchment population provided by article | 17.5 |
Darbar | 2000–2005 | Australia | Prospective hospital-based study | 47.3–78.7 | 80 | - | - | 10.0 |
Farley | 1989–1990 | North America | Population-based surveillance | 18–99 | 140 | 4.4 | Provided by article | 21.0 |
Francois Watkins | 2008–2016 | North America | Population-based surveillance | ≥ 18 | 21250 | 9.5 | Average of incidence of surveillance years provided by article | 6.5 |
Fujiya | 2002–2014 | Asia | Retrospective cohort study | 24–91 | 52 | 2.5 | Provided by article | 5.8 |
Georges | 1991–2006 | Europe | Population-based surveillance | 15–64 | - | 1.8 | Provided by article. Not used for the meta-analysis due to information on denominators not available | - |
>64 | 4.1(1991) 9.1(2006) | |||||||
Gimenez | 1983–1993 | Europe | Retrospective study | 40–80 | 35 | 0.58 | Estimated from cases per catchment population provided by article | 8.7 |
Gudjonsdottir | 2004–2009 | Europe | Population-based surveillance | 23–103 | 317 | 3.47 | Estimated from cases per catchment population provided by article | 12.0 |
Huang | 2001–2003 | Asia | Retrospective study | 22–89 | 94 | - | - | 20.2 |
Jenkins | 2006–2009 | Europe | Population-based surveillance | 28–84 | 17 | 0.69 | Provided by article | 0.0 |
Jones | 2000–2003 | Europe | Prospective hospital-based study | > 60 | 70 | 11.0 | Estimated from cases per catchment population provided by article | - |
Jump | 2008–2017 | North America | Prospective cohort study | ≥ 18 | 5497 | - | - | |
Kalimuddin | 2011–2015 | Asia | Retrospective cohort study | Nonpregnant adults | 408 | - | - | 7.4 |
Lamagni | 1991–2010 | Europe | Retrospective study | ≥ 15 | 13376 | 1.66 | Average of incidence of surveillance years provided by article | - |
Lambertsen | 1999–2004 | Europe | Population-based surveillance | 16–99 | 411 | 2.7 | Average of incidence of surveillance years provided by article | 14.0 |
Lee | 1991–1999 | Asia | Prospective hospital-based study | 18–85 | 71 | - | - | 7.0 |
Lopardo | 1998–1999 | South America | Prospective hospital-based study | 21–83 | 31 | - | - | 12.9 |
Matsubara | 1998–2007 | Asia | Retrospective hospital-based study | 29–90 | 52 | 1.04 | Estimated from cases per catchment population provided by article | 13.5 |
Morozumi | 2010–2013 | Asia | Prospective study | 19- >90 | 443 | - | - | 10.2 |
Mosites | 2002–2015 | North America | Retrospective study | ≥ 18 | 6 | - | - | 33.0 |
Perovic | 1995–1997 | Africa | Retrospective hospital-based study | 22–87 | 40 | 0.44 | Estimated from cases per catchment population provided by article | 35.0 |
Phares | 1999–2005 | North America | Population-based surveillance | ≥ 15 | 11663 | 6.95 | Average of incidence of surveillance years provided by article | 10.3 |
Ruppen | 1998–2015 | Europe | Retrospective hospital-based study | ≥ 65 | 171 | - | - | 5.0 |
Schrag | 1993–1998 | North America | Population-based surveillance | ≥ 15 | 5293 | 11.9α | Average of incidence by age group provided by article | 11.5 |
Schwartz | 1982–1983 | North America | Retrospective population-based surveillance | ≥ 20 | 56 | 2.4 | Provided by article | - |
Shelburne | 2000–2011 | North America | Retrospective hospital-based study | 27–86 | 147 | - | - | 6.0 |
Skoff | 2007 | North America | Population-based surveillance | 18–105 | 1546 | 7.3 | Provided by article | 7.5 |
Slotved | 2005–2018 | Europe | Population-based surveillance | 20–64 | - | 1.35 | Not used for the meta-analysis. Number of cases by age group not extractable | - |
65–74 | 5.35 | |||||||
> 75 | 9.80 | |||||||
Tyrrell | 1996 | North America | Population-based surveillance | ≥ 15 | 91 | 4.1 | Provided by article | 5.5 |
Wilder-Smith | 1998 | Asia | Prospective hospital-based study | 24–63 | 11 | 1.1 | Estimated from cases per catchment population provided by article | 9.1 |
α: Incidence in 2008 only.